基因芯片:春天在哪里

基因芯片技术尚未完全成熟,却挡不住它的商业化脚步。俞菁(化名)是一名手语翻译,她的妈妈因为小时候一次注射庆大霉素致聋,但她自己的听力得以保持健全。俞菁有一位好姐妹,情况却正好相反,她

THE SPRING OF GENE CHIPS STILL FAR

Believe it or not,there are over 30,000 new deafness patients in China every year,60% of which are caused by deafening genes.Actually,doctors know some drugs may trigger dea f ness.But as the traditional gene detection methods are unpractical,they just had to let such tragedies continue to happen.Good news is that deafness gene chip testing technology has been invented by CapitalBio Sciences Co.,Ltd.(CapitalBio).The chip covers nine mutational sites of four most frequently seen deafening genes in Chinese population.It takes only five hours and several hundreds of Yuan to complete a testing,much faster and cheaper than before,according to Zhao Zhixian,Marketing Director of CapitalBio.The technology enables doctors to see the individual differences of patients and greatly elevates the accuracy in diagnosis and treatment.But it has to be based on a large amount of scientific research in a long period of time.Though the gene chip technology is not mature enough at the moment,some cannot wait to bring it to the market and make profits.Since the new technology faces difficulties in market access and lacks specialists,the spring of gene chips is yet to come.